Kestra Advisory Services’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Kestra Advisory Services's LLY Position: Q1 2026 in Review
Kestra Advisory Services increased its Eli Lilly (LLY) stake by 14% in Q1 2026, buying an estimated $14.8M and bringing the position to 122,730 shares worth $113M. The position accounts for 0.43% of the portfolio, ranked #32.
Kestra Advisory Services first reported a position in LLY in Q3 2020 and has held it in 23 quarters since. The position peaked at $116M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Kestra Advisory Services held 122,730 shares of Eli Lilly worth $113M as of Q1 2026.
- Kestra Advisory Services bought 14,606 Eli Lilly shares in Q1 2026, an estimated $14.8M.
- Eli Lilly made up 0.43% of Kestra Advisory Services's portfolio in Q1 2026, its #32 holding.
- Kestra Advisory Services first reported a position in Eli Lilly in Q3 2020 and has held it in 23 quarters since.
- Kestra Advisory Services's Eli Lilly position peaked at $116M in Q4 2025.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Kestra Advisory Services's 13F filing for Q1 2026, filed 30 Apr 2026.